1. Home
  2. INSG vs CRBU Comparison

INSG vs CRBU Comparison

Compare INSG & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$10.52

Market Cap

190.1M

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.66

Market Cap

192.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSG
CRBU
Founded
1996
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medicinal Chemicals and Botanical Products
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.1M
192.4M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
INSG
CRBU
Price
$10.52
$1.66
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$15.33
$10.75
AVG Volume (30 Days)
448.1K
1.8M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.64
EPS
0.65
N/A
Revenue
$313,832,000.00
N/A
Revenue This Year
$16.21
$1.63
Revenue Next Year
$13.28
$10.93
P/E Ratio
$15.95
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.28
$1.04
52 Week High
$21.90
$3.53

Technical Indicators

Market Signals
Indicator
INSG
CRBU
Relative Strength Index (RSI) 35.08 32.70
Support Level $9.35 $1.39
Resistance Level $12.61 $1.73
Average True Range (ATR) 1.23 0.17
MACD -0.29 -0.06
Stochastic Oscillator 16.10 5.67

Price Performance

Historical Comparison
INSG
CRBU

About INSG Inseego Corp.

Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: